The bill amends sections of the Hawaii Revised Statutes related to health insurance coverage. By eliminating cost-sharing for breast cancer-related examinations, the bill seeks to enhance early detection and encourage preventive care among women, thereby improving health outcomes. The legislation is expected to significantly reduce out-of-pocket expenses for patients needing these critical health services, especially for those with higher risks of breast cancer due to personal or family medical histories. It takes effect on January 1, 2027, affecting all new or renewed health insurance contracts thereafter.
Summary
House Bill 2366 aims to prohibit cost-sharing requirements for breast cancer screenings, supplemental breast examinations, and diagnostic breast examinations under individual, group health insurance policies, and health maintenance organization plans in Hawaii. The legislation specifies that insurers cannot impose deductibles, coinsurance, or copayments for these services unless such practices would jeopardize the insured's eligibility for a high deductible health plan under federal guidelines. This provision is designed to ensure that individuals can access necessary screenings and diagnostic services without financial barriers.
Contention
Although the bill is aimed at improving access to vital health screenings, potential points of contention may arise from insurer concerns regarding the financial implications of mandated coverage without cost-sharing. Insurers might argue that while the legislation benefits consumers, it could lead to increased premiums or constraints on coverage options. Additionally, discussions around the eligibility criteria for high deductible plans may also surface, particularly regarding how the bill aligns with existing federal regulations. Overall, while proponents view it as a crucial step towards better health care access, opponents may worry about its economic repercussions on the insurance market.